Previous close | 10.00 |
Open | N/A |
Bid | 11.00 |
Ask | 15.50 |
Strike | 70.00 |
Expiry date | 2025-01-17 |
Day's range | 10.00 - 10.00 |
Contract range | N/A |
Volume | |
Open interest | N/A |
Catalent's (CTLT) new tie-up to support the development and commercial manufacturing of safe, high-quality AAV gene therapies to provide life-saving treatments to cancer patients.
Catalent (CTLT) reports a solid revenue uptick in third-quarter fiscal 2024 despite lower revenues in Biologics segments.
Insightful Analysis of Catalent Inc's Strengths, Weaknesses, Opportunities, and Threats